To assess whether expression of the 576 candidate genes nominated by the screens was associated with local immune cytolytic activity in patient tumors (quantified using granzyme A and perforin 1 bulk transcriptome data)23, we analyzed gene expression of 33 tumor types from The Cancer Genome Atlas (TCGA). The gene discussed is PRF1; the disease is neoplasm.